Chronic lymphocytic leukaemia: open trials in Hungary

8 open trials have a site in Hungary. Registry data; only the trial team decides who can take part.

NCT06588478
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Trial Treatment · Phase 2 · Loxo Oncology, Inc.
Dél-Pesti Centrumkórház, Budapest · Semmelweis Egyetem, Budapest · Pécsi Tudományegyetem Klinikai Központ, Pécs · Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, Szeged
Registry updated 2026-11-04
NCT07218341
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Trial Treatment · Phase 4 · Eli Lilly and Company
Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Budapest · Debreceni Egyetem, Debrecen
Registry updated 2026-11-04
NCT04728893
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Orszagos Onkologiai Intezet (Site 1200), Budapest · Debreceni Egyetem Klinikai Kozpont (Site 1201), Debrecen · Szabolcs Szatmár Bereg Vármegyei Oktatókórház (Site 1206), Nyíregyháza · Pecsi Tudomanyegyetem Altalanos Orvostudomanyi Kar (Site 1202), Pécs
Registry updated 2026-10-27
NCT05645107
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Trial Treatment · Phase 3 · Grifols Therapeutics LLC
Del-Pesti Centrumkorhaz Orszagos Hematologiai Es Infektologiai Intezet, Budapest IX · Orszagos Onkologiai Intezet, Budapest XII · University of Debrecen, Debrecen · Markhot Ferenc Oktatokorhaz es Rendelointezet, Eger · Petz Aladar Egyetemi Oktato Korhaz, Győr · University of Szeged, Szeged · Fejér Megyei Szent György Egyetemi Oktató Kórház, Székesfehérvár · Tolna Megyei Balassa Janos Korhaz, Szekszárd
Registry updated 2026-09-30
2025-521088-10-00
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor (BTKi) and a Bcell Lymphoma-2 Inhibitor (BCL-2i) (DAYBreak CLL-201)
Trial Treatment · Phase 2 · Nurix Therapeutics Inc.
University of Debrecen, Debrecen
Registry updated 2026-08-24
2024-515654-25-00
A Phase Ib/II Study of APG-2575 as a Single Agent or in Combination with Other Therapeutic Agents in Patients with Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Trial Treatment · Phase 1/2 · Ascentage Pharma Group Inc.
University of Debrecen, Debrecen · Somogy Vármegyei Kaposi Mór Oktató Kórház, Kaposvár · Szabolcs Szatmár Bereg Vármegyei Oktatókórház, Nyíregyháza
Registry updated 2026-08-18
NCT05254743
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Trial Treatment · Phase 3 · Loxo Oncology, Inc.
University of Debrecen, Debrecen · Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz, Szombathely
Registry updated 2026-08-17
NCT06104566
Global Trial in APG2575 for Patients With CLL/SLL
Trial Treatment · Phase 3 · Ascentage Pharma Group Inc.
Semmelweis University, Budapest VIII · University of Debrecen, Debrecen · Szabolcs Szatmár Bereg Vármegyei Oktatókórház, Nyíregyháza
Registry updated 2026-06-18

All Chronic lymphocytic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error